FDA Issues Warning Letter to Oasis Medical
August 05, 2025
August 05, 2025
WASHINGTON, Aug. 5 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Oasis Medical from the Center for Drug Evaluation and Research:
Recipient: Recipient Name
Mr. Norman Craig Delgado
Recipient Title: President and CEO, Oasis Medical, Inc., 514 S. Vermont Avenue, Glendora, CA 91741, United States
Issuing Office: United States
Warning Letter 320-25-93
Recipient: Recipient Name
Mr. Norman Craig Delgado
Recipient Title: President and CEO, Oasis Medical, Inc., 514 S. Vermont Avenue, Glendora, CA 91741, United States
Issuing Office: United States
Warning Letter 320-25-93